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Short communication
Up-regulation of p21 WAF1 expression in myeloid cells is
activated by the protein kinase C pathway
J Schwaller', UR Peters'2, Th Pabst1, G Niklaus', DE Macfarlane4, MF Fey'2 and A Tobler13
'The Department of Clinical Research, 21nstitute of Medical Oncology, 3Central Haematology Laboratory, University of Berne, Berne, Switzerland;
and 4Department of Medicine, Veterans Administratio6 Hospital and University of Iowa, IA, USA
Summary Phorbol-12-myristate-13-acetate (PMA) induces p21 WAF-1 expression in human myeloid leukaemic HL-60 cells. We show that this
induction is specifically mediated by protein kinase C (PKC). In addition, the PKC inhibitor Ro 31-8220 with predominant PKC-a isoform
specificity almost completely inhibited PMA-induced up-regulation of p21 WAFi in HL-60 cells as well as in the myelomonocytic leukaemic U937
cells. Pretreatment of HL-60 cells with Ro 31-8220 also inhibited PMA-induced activation of c-raf-1, a known PKC a target. In the phorbol
ester-tolerant HL-60 subline (PET) with PKC-P isoform deficiency PMA or bryostatin-1 induced p21 WAFI expression, but to a lesser extent than
in wild-type HL-60 cells. In PET cells, Ro 31-8220 also inhibited PMA and bryostatin-1-induced up-regulation of p21 WAFi expression. Our
findings indicate that at least in HL-60 cells up-regulation of p21 WAF-1 is specifically activated by PKC. We suggest that PKC isoforms other
than 1B, presumably the PKC-a isoform, are involved in this process.
Cancer is characterized by profound alterations both in cell cycle
control and in cellular differentiation. Such mechanisms can be
studied with the help of cell line models, for example leukaemic
cell lines in which both proliferation and differentiation
programmes may be analysed. Phorbol ester-induced differentia-
tion ofhuman leukaemic myeloid HL-60 cells towards monocyte-
like cells is associated with growth arrest in the G, phase of the
cell cycle. The CKI p21WAFJ (wild-type p53-activatedftagment-1)
is a mediator of G1 cycle arrest induced by wild-type p53 protein
(El-Deiry et al, 1993), and in human leukaemiap21WAFI expression
may be up-regulated independently from p53 (Schwaller et al,
1995; Zhang et al, 1995; Blagosklonny et al, 1996).
Phorbol esters are potent activators ofprotein kinase C (PKC), a
family of serine-threonine protein kinases that act as a central
mediators ofsignal transduction pathways (Castagna, 1987). InHL-
60cells concordant expression pattern ofPKC-a and-0 isoenzymes
is seen during phorbol ester-induced monocytic differentiation
(Aihara et al, 1991; Edashige et al, 1992). To examine the role of
PKC in up-regulating p21WAFJ expression, we modulated p21WAFI
expression by several PKC activators and inhibitors. We also inves-
tigated the expression ofc-raf-1, a protein serine-threonine kinase
required forp21WAFI induction andup-stream regulation ofmitogen-
activated protein (MAP) kinase (Blagosklonny et al, 1995).
MATERIAL AND METHODS
Reagents
PMA, 413-phorbol 12,13-didecanoate, 4a-phorbol-12-13-didecan-
oate and mezerein (all from Sigma Chemical, St Louis, MO,
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USA), were dissolved in acetone to a stock solution of 1 mm and
stored at -20°C. Ro 31-8220 ('compound 3"; provided by Dr G
Lawton, Roche Research Centre, Welwyn Garden City, Herts,
UK), and bryostatin-1 (provided by DrGR Pettit, CancerResearch
Institute, Tempe, AZ, USA) were dissolved in dimethylsulphoxide
(DMSO; Merck Chemical, Darmstadt, Germany) to stock solu-
tions of 1 mM.
Cell cultures
HL-60-cells (American Type Tissue Culture Collection, ATCC,
Rockville, MD, USA), S-cells (HL-60, wild-type) and PET-cells
(phorbol-ester tolerant HL-60) provided by Dr DE Macfarlane,
University of lowa, IA, USA, were all cultured at low numbers
of passages (< 35) in McCoy's supplemented with 10% heat-
inactivated fetal bovine serum in 5% carbon dioxide at 37°C.
Normal diploid lung fibroblasts (WI-38; ATCC), expressing high
levels of p21WAFI, and a human breast cancer cell line MCF7
(provided by Dr A Ziemiecki, Department of Clinical Research,
University of Berne, Switzerland), expressing high levels of
c-raf-1, served as positive controls (Blagosklonny et al, 1995;
Schwaller et al, 1995).
Northern blot analysis
RNA extraction and Northern blotting as well as hybridization
were performed as described previously (Schwaller et al, 1995).
Human cDNA probes were: p21WAFI (2.1 kb; BamHI-HindIII)
from pCEP (El-Deiry et al, 1993), and 3-actin (0.7 kb; EcoRI-
BamHI, from pHF-A-3'UTR (Schwaller et al, 1995).
Western blot analysis
Total cellular protein was extracted and Western blotted as
described (Schwaller et al, 1995). A polyclonal rabbit anti-human
p2lWAFJ specific antibody (C-19; Santa Cruz, Santa Cruz, CA,
1554p21WAF1 expression in myeloidcells 1555
A 15 h
E Mezerein
4l-Phorbol 4a-Phorbol8 > (nM)
(nm) (nm) S O ISl
0 JD
8 o 5 .' co o_ o e _ _ __ DX D.__ ~~~~oD
Ro 31-8220 +
Bryo (5 nM) - Bryo (5 nM) -
.5c .5 co oS
.6 G
-
o C E _ _ E r <
0 m m m 0 0
m m m o 2~~~0
p21WAFlmRNA
13-Actin mRNA
B
8 0 g S z
c
e _ _ _ c&J
L
o o o ~~~~-
0 m
a. a. L <
' C:L CL 0 2
p21WAFlmRNA
,-Actin mRNA
B
Bryo (5 nM)
II s z
VI CO SD
Ro31-8220 +
Bryo (5 nM)
_ co coa
p21 WAFI
-2.1 kb
-2.1 kb
- 21 kDa
Figure 3 Modulation of p21 WAF1 expression of HL-60 cells by bryostatin-1.
Cells were exposed to bryostatin-1 (Bryo; 5 x 10-9 M) for 1-6 h with or without
preincubation with Ro 31-8220 (1 mM) for 1 h. Northern blot (A) and Western
blot analyses (B) of the same experiment
Figure 1 Effect of different phorbol derivatives on p21 WAF1 expression in
HL-60 cells. The cells were treated with 43-phorbol 12,13-didecanoate (4p-
phorbol), 4a-phorbol 12-13-didecanoate (4a-phorbol), mezerein and phorbol-
12-myristate-13-acetate (PMA) as indicated. Northern blot (A) and Western
blot (B) analyses of the same experiment. The same results were obtained in
three independent experiments
USA) and a polyclonal anti-c-raf- 1 antibody (Santa Cruz) were
used at dilutions of 1:250 and 1:750 respectively.
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phorbol ester derivatives
PMA, 43-phorbol 12,13-didecanoate and mezerein are biologi-
cally active diterpenes that bind to and activate PKC. After treat-
ment of the cells with these agents p21WAF) mRNA and protein
expression was up-regulated (Figure 1). Mezerein was the most
-2.1 kb
potent inducer followed by
PMA and 4P-phorbol 12,13-didecan-
oate. To distinguish between PKC-specific receptor-mediated and
non-specific effects, HL-60 cells were treated with 4ax-phorbol-
-2.1 I4* 12-13-didecanoate (10-1500 nM). This agent is structurally
closely related to the tumour promoting diterpenes but displays
very low affinity for PKC (Castagna, 1987). No increase of
p2lWAF) expression was seen. Thus, in HL-60 cells induction of
p2lWAFJ expression by PMA is mediated by activation ofPKC.
Dose-dependent inhibition of PMA-induced p21 WAFI
expression by the PKC inhibitor Ro 31-8220
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Figure 2 (A) Inhibition of PMA-induced p21 WAFi mRNA expression in HL-60
cells by the PKC inhibitor Ro 31-8220. Cells were preincubated for 1 h with
Ro 31-8220 and then exposed to PMA (60 ng ml-', 10-8 M) for 15 h. Northern
blot analysis. (B) Inhibition of PMA-induced p21 WAF1 protein expression in
HL-60 cells and U937 cells by Ro 31-8220. Western blot analysis
In contrast to commonly used PKC inhibitors, for example stau-
rosporine, Ro 31-8220 is less potent but more selective (Wilkinson
et al, 1993). Preincubation with Ro 31-8220 (500-1000 nM) for
1 h almost completely inhibited PMA-induced p21WAFI mRNA and
protein expression (Figure 2A and B) in HL-60 cells and
prevented their differentiation as shown by lack of both esterase
staining and adherence to plastic. Cell viability remained > 90%.
The same experiments were performed with the myelomonocytic
U937 cells. Similar to HL-60 cells, Ro 31-8220 completely inhib-
ited the PMA-induced protein expression ofp21WAF) (Figure 2B).
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Figure 4 Modulation of p21 WAFI expression in phorbol ester-tolerant HL-60 cells (PET) compared with wild-type (S) cells by PMA with or without inhibition by
Ro 31-8220. The cells were exposed to PMA (60 ng ml-', 10-8 M) for 1-24 h with or without preincubation with Ro 31-8220 (1 mM) for 1 h. Northern (A) and
Western blot analysis (B) of the same experiment
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Figure 5 Inhibition of PMA-induced c-raf-1 protein phosphorylation in HL-
60 cells by Ro 31-8220. The cells were preincubated with Ro-31-8220 for 1 h
and then exposed to PMA (60 ng m-1) for 15 h. Western blot analyses
Bryostatin-1 induced p21 WAF1 expression is also
inhibited by Ro 31-8220
Bryostatins activate PKC but lack tumour-promoting properties
(Smith et al, 1985). Continuous exposure of primary cultures of
human acute leukaemia cells and various HL-60 cell clones to
bryostatin-1 promotes growth arrest and terminal differentiation
towards a monocyte-macrophage-like cell (Stone et al, 1988).
Treatment of our HL-60 cell clone with bryostatin- 1 (0.1-
1000 nM) induced peak levels of p21WAF) mRNA expression at
concentrations of 1-10 nM. A rapid induction of p21 WAFI mRNA
and protein expression was seen after approximately 90 min of
bryostatin-1 exposure (5 nM; Figure 3A and B), but did not occur
in cells preincubated for 1 h with Ro 31-8220.
p21 WAF1 expression in the phorbol ester-tolerant HL-60
subline PET by PMA and Ro 31-8220
Phorbol ester resistance ofthe PET variant ofHL-60 cells is due to
lack of PKC-1 expression (Macfarlane et al, 1988, 1994).
Compared with HL-60 wild-type cells (S cells), a similar but
more modest up-regulation ofp21 WAFI mRNA was seen after PMA
treatment for 15 h with PMA. Pretreatment of PET cells and S
cells with Ro 31-8220 inhibited PMA-induced p21WAFI mRNA and
protein expression, although inhibition was less pronounced in
PET cells (Figure 4). The same pattern was seen with bryostatin-1.
PMA induced c-raf-1 protein phosphorylation is
inhibited by Ro 31-8220
In human MCF7 breast carcinoma cells induction of p21WAFI by
PMA is mediated via PKC-ax activation of c-raf-1 (Kolch et al,
1993; Blagosklonny et al, 1995). We confirm that in HL-60 cells
PMA phosphorylates c-raf-1 protein resulting in a band shift on
the Western blot and show that preincubation with Ro 31-8220
almost completely inhibited PMA-induced c-raf-1 phosphoryla-
tion (Figure 5).
DISCUSSION
The PKC multigene family consists of at least 11 known isoforms
thought to regulate a variety of cellular activities (Blobe et al,
1994). HL-60 cells contain PKC-a, PKC-0 and PKC-6, but not
PKC-y (Aihara et al, 1991; Edashige et al, 1992). Although many
agents are known to block PKC activity, only few are highly
specific and none of them exclusively inhibit a given PKC-
isoform. We found almost complete inhibition of PMA-induced
p21WAFI up-regulation by the rather specific PKC-ax inhibitor Ro
31-8220, which indicates that this isoform might play an important
role in mediating this effect (Wilkinson et al, 1993). The PMA
resistance of two PKCf-deficient HL60 sublines (PET, HL-525)
can be restored by either PKC-P gene transfection or 1,25-dihy-
droxyvitamin D3 induced up-regulation of PKC-3 (Macfarlane et
al, 1994; Tonetti et al, 1994). In our experiments, PMA-induced
PET cells showed an expression pattern similar to wild-type HL-
60 cells. Up-regulation ofp21WAFI expression in PET cells was also
inhibited by Ro 31-8220, which strengthens the view that PKC
isoforms other than PKC-, might also be involved in this process.
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However, as no PKC inhibitor is absolutely isoform specific, two
other PKC isoforms (a, 6) are also reasonable candidates.
Interestingly, in several cell lines, increase in PKC-a expression
was accompanied by growth inhibition and differentiation
(Kindregan et al, 1994). PKC-a activates c-raf-1 by direct phos-
phorylation and c-raf-l in turn can activate the mitogen-activated
protein (MAP) kinases (Kolch et al, 1993). Two recent reports
have indicated that induction of p21WAFI expression is dependent
on c-raf-1 and activation of MAP kinases (Blagosklonny et al,
1995; Liu et al, 1996). We found that in HL-60 cells the PMA-
induced c-raf-1 phosphorylation can almost completely be
prevented by Ro 31-8220, perhaps pointing to a role of PKCa in
the induction ofp21WAF) expression in these cells.
In conclusion, our experiments show that in the HL-60 cell
leukaemia model up-regulation ofthe p2lWAFI is mediated by PKC
and PKC isoforms other than i presumably the a type are
involved.
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